Study guide

PUK, interstitial keratitis and scleritis

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

PUK, interstitial keratitis and scleritis

Key Takeaways Explain This Topic AI

Peripheral ulceration with thinning requires urgent assessment of infection, perforation and systemic inflammatory disease.

Destructive scleritis can indicate systemic vasculitis and is not managed adequately by surface lubrication alone.

Blanching and ultrasound signs support differentiation but cannot replace the complete clinical assessment.

Last updated: October 2026

Peripheral Ulcerative Keratitis

Peripheral ulcerative keratitis (PUK) is a crescentic inflammatory ulcer with epithelial loss and stromal thinning near the limbus. Pain, photophobia, injection and adjacent scleritis may occur, but presentation varies. The peripheral vascular/immune environment permits inflammatory-cell recruitment and collagen degradation. The immediate questions are whether infection is present, whether thinning threatens perforation and whether an associated systemic vasculitis needs urgent treatment.

Assess acuity, defect extent/depth, infiltrate, sclera, anterior chamber and leakage when safe. Avoid pressure on a very thin cornea. Obtain microbiological samples for a possible infectious ulcer without delaying antimicrobial care. Ask about rheumatoid arthritis, respiratory/renal symptoms, skin disease, inflammatory bowel disease, prior surgery, medication and systemic infection risk. Rheumatoid disease and granulomatosis with polyangiitis (GPA) are important associations, but an unreferenced percentage does not establish the diagnosis.

Immune-mediated PUK can signal serious systemic disease and needs urgent corneal and rheumatology care. Systemic corticosteroids and steroid-sparing treatment may be required once infection is excluded or appropriately covered; use targeted immune treatment rather than automatically administering it before assessment. GPA may need rituximab or cyclophosphamide-based induction according to the systemic team. Topical steroid monotherapy is inadequate for systemic vasculitic PUK and can worsen infection or melting. Local lubrication, anticollagenolytic measures and protective procedures complement treatment of the cause. Glue, amniotic membrane or tectonic grafting may be needed for impending or established perforation, with size, location and tissue viability guiding choice.

Mooren Ulcer and Interstitial Disease

Mooren ulcer is a painful progressive peripheral ulcer with an undermined edge, diagnosed after excluding infection and systemic causes. Absence of a recognised systemic disease does not make every peripheral ulcer Mooren disease. Assess both eyes, age, progression and scleral involvement; treatment ranges from local immune control to specialist systemic therapy and reconstruction.

Interstitial keratitis is inflammation primarily within the stroma, often with vascularisation and little primary epithelial ulceration. Causes include syphilis, herpes, TB-associated disease and immune disorders. Distinguish an active infectious process from immune-mediated scarring before prescribing steroids. Ghost vessels indicate prior vascularisation rather than current cause. Syphilis testing needs stage/treatment interpretation and systemic antimicrobial treatment when indicated.

Cogan syndrome classically combines non-syphilitic interstitial keratitis with audiovestibular disease. New hearing symptoms or systemic vascular signs warrant urgent medical/ENT assessment; treatment is chosen for organ threat and infection exclusion. A corneal appearance alone does not diagnose Cogan or justify one automatic high-dose regimen. Review drug toxicity, autoimmune and infectious alternatives.

Episcleritis versus Scleritis

Episcleritis usually causes local superficial injection with irritation and relatively preserved vision. Scleritis often produces deeper violaceous injection, tenderness and substantial boring pain, sometimes radiating or waking the patient. Pain can be reduced in necrotising disease without inflammation or neuropathy, so absence of severe pain is not reassuring by itself. Examine cornea, pressure, pupils and posterior segment and assess whether the globe is threatened.

  • Feature Episcleritis Scleritis
  • Tissue Superficial episcleral vessels Deeper sclera with possible thinning
  • Symptoms Often mild discomfort Often deep pain and tenderness
  • Vision Usually preserved Can be affected by associated disease
  • Phenylephrine Superficial vessels often blanch Deep vessels may persist; this is supportive, not definitive

Management Lubrication and selected anti-inflammatory care Cause- and severity-based systemic assessment/treatment

Phenylephrine testing is not an infallible discriminator and may be inappropriate with particular cardiovascular or ocular conditions. Consider keratitis, uveitis, angle closure and orbital disease if symptoms or findings do not fit. Recurrent episcleritis may justify systemic review guided by history; every mild first episode does not need an indiscriminate laboratory panel.

Scleritis Classification and Management

Anterior scleritis may be diffuse, nodular or necrotising. Necrotising disease threatens globe integrity and may accompany systemic vasculitis. Infectious scleritis is particularly relevant after surgery/trauma and must be distinguished from immune disease before escalating steroids. Posterior scleritis can cause pain, reduced vision, disc swelling, choroidal folds or an exudative detachment. Ultrasound may show scleral thickening and a T-sign from fluid around the optic nerve, but absence of that sign does not exclude the diagnosis.

Mild non-necrotising immune disease may respond to an oral NSAID if renal, gastrointestinal, cardiovascular and other risks permit. More severe or resistant disease may require systemic corticosteroids and immunomodulation, selected with medical specialists. Topical therapy may be an adjunct but usually does not adequately control deeper severe disease. Do not provide a high-dose indomethacin recipe or assume every posterior case needs the same IV steroid/cyclophosphamide combination.

Investigation follows the phenotype and systemic history: blood count, renal/urine assessment, inflammatory markers and targeted infection/autoimmune tests may identify an actionable cause. Monitor pain, inflammation, thinning, pressure and posterior complications and reassess the diagnosis if treatment fails. Provide urgent return advice for reduced vision, new leakage, escalating pain or systemic deterioration.

Clinical Reasoning Example

A patient with a painful peripheral crescentic defect, stromal loss and deep injection has a threatening ulcer and possible scleritis. Describe the size/depth and assess leakage without pressure, obtain infection-directed samples, and arrange urgent corneal/systemic review. A history of arthritis increases concern for immune disease but does not eliminate infection. Starting only a steroid drop would fail to address the systemic threat and could worsen microbial disease. Once the cause is assessed, combine systemic treatment with local protection and close review.